Effects of insulin on rat renal microvessels: Studies in the isolated perfused hydronephrotic kidney  by Hayashi, Koichi et al.
Kidney International, Vol. 51(1997), pp. 1507—1513
Effects of insulin on rat renal microvessels: Studies in the
isolated perfused hydronephrotic kidney
KoIcHI HAYASHI, KEIJI FUJIWARA, KIYOSHI Oic&, TAKAHIKO NAGAHAMA, HIROTO MATSUDA,
and TAKAO SARUTA
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
Effects of insulin on rat renal microvessels: Studies in the isolated
perfused hydronephrotic kidney. Although insulin is demonstrated to
decrease vascular tone, the role of insulin in renal microcirculation has not
been fully determined. In the present study, the effect of insulin on renal
microvascular tone was assessed using the isolated perfused hydrone-
phrotic rat kidney. Insulin (300 U/ml) had no effect on the basal renal
microvessel diameter. In addition, insulin did not alter myogenic (that is,
pressure-induced) constriction of preglomerular microvessels, with similar
magnitude of constriction observed in response to elevated renal perfu-
sion pressure from 80 to 180 mm Hg (interlobular artely, —23 3% vs.
—19 4%; afferent arteriole, —22 3% vs. —21 4%, for control and
insulin, respectively). In striking contrast, insulin dose-dependently re-
versed the norepinephrine (NE)-induced tone of interlobular arteries,
afferent arterioles, and efferent arterioles, with 94 9%, 104 6%, and
86 10% reversal at 300 rU/ml, respectively. These vasodilator actions
were markedly inhibited by N-Arg; in the presence of N-Arg, insulin (300
j.tU/ml) exerted only a modest dilator action on interlobular arteries (24
9% reversal), afferent arterioles (23 10% reversal), and efferent
arterioles (14 9% reversal). A similar renal microvascular responsive-
ness to insulin was also observed during angiotensin TI (Arig 11)-induced
constriction. In conclusion, the ability of insulin to dilate the renal
microvasculature differs, with marked inhibitory action during NE/Ang
Il-induced constriction and almost no inhibition during myogenic constric-
tion. Furthermore, the present study suggests that the insulin-induced
renal vasodilation is mediated by nitric oxide.
Insulin, mandatory for the homeostasis of glucose metabolism,
has been the focus of recent investigations on cardiovascular
medicine. Hyperinsulinemia and insulin resistance are demon-
strated to be associated with systemic hypertension [1—3], and
augmented sensitivity to vasopressor hormones [4]. Conversely,
recent studies indicate that insulin increases forearm blood flow in
humans [5, 6]. These observations are consistent with the premise
that insulin is a vasoactive hormone. Additionally, a growing
amount of evidence indicates that insulin dilates the renal vascu-
lature. Thus, insulin is reported to increase renal blood flow in
vivo [7] and in the isolated perfused kidney [8]. The mechanisms
or sites of the insulin-induced renal vasodilatiori, however, remain
poorly determined [9].
Nitric oxide, identified as an endothelium-derived relaxing
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factor [10], has been proven to constitute an important regulatory
autacoid of the vascular tone in several vital organs. Recent
investigations have demonstrated that insulin-induced vasodila-
tion is associated in part with nitric oxide [11, 12]. Thus, the
inhibition of nitric oxide synthesis attenuated the insulin-induced
vasodilation of skeletal muscle. Although previous studies have
indicated that insulin attenuates the agonist-induced intracellular
calcium response in vascular smooth muscle cells [13] and mes-
angial cells [14], the role of nitric oxide in mediating insulin-
induced relaxation of renal microvascular beds is poorly under-
stood.
In the present study, we investigated the vasodilator effects of
insulin on renal preglomerular (that is, interlobular arteries and
afferent arterioles) and postglomerular vessels (efferent arte-
rioles) during norepinephrine (NE)-, angiotensin II (Ang II)-, and
pressure-induced (that is, myogenic) constriction in Sprague-
Dawley (S-D) rats. Furthermore, whether nitric oxide mediates
the insulin-induced alterations in microvascular tone was as-
sessed. In order to directly visualize the renal microvasculature,
we used the isolated perfused hydronephrotic rat kidney model
[15—18].
Methods
Chronic hydronephrosis was established to facilitate subse-
quent visualization of the renal microcirculation in isolated per-
fused kidneys [15—18]. Six-week-old male S-D rats were anesthe-
tized with ether. The right ureter of each animal was ligated
through a mid-abdominal incision. Following 8 to 10 weeks, at
which time renal tubular atrophy had progressed to a stage that
allowed direct microscopic visualization of renal microvessels [19],
the kidneys were harvested for perfusion study. All procedures
were performed following the guidelines of the Animal Care
Committee of Keio University.
Donor animals were anesthetized with ether, and the abdomi-
nal cavity was exposed by midline incision. The renal artery of the
hydronephrotic kidney was cannulated in situ across the aorta
through the superior mesenteric artery. Warm oxygenated me-
dium was perfused throughout the cannulation procedure. The
hydronephrotic kidney was excised and placed on the stage of an
inverted microscope (IMT-2; Olympus, Tokyo, Japan) modified to
accommodate a heated chamber equipped with a thin glass
viewing port on the bottom surface. Kidneys were allowed to
equilibrate for at least 30 minutes before initiating experiments.
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Kidneys were perfused with media consisting of a Krebs-Ringer
bicarbonate buffer containing 5 mmol/liter D-glucose, 7.5% bo-
vine serum albumin (Sigma Chemical Co., St. Louis, MO, USA),
and a complement of amino acids [201. The perfusion apparatus is
illustrated in our previous publication [15]. The perfusion media
(100 ml) was saturated with a gas mixture of 95% 02/5% CO2
within a pressurized reservoir. The perfusion pressure, monitored
at the level of the renal artery, was altered by adjusting the
back-pressure-type regulator (Model IOBP; Fairchild Industrial
Products Co., Winston-Salem, NC, USA), which controlled the
exit of gas from the media reservoir.
Vessel diameters were measured as detailed in a previous
publication [15—18]. In brief, video images from a video camera
(model XC-77; Sony, Tokyo, Japan) were recorded with a video
cassette recorder and transmitted to an computer (PS55-5551;
IBM Japan, Tokyo, Japan) equipped with a video display board
(Targa 16+; Truevision, Indianapolis, IN, USA). Vessel diame-
ters were estimated with an automated program custom designed
to permit determination of the mean distance between parallel
edges of the selected vessels [15—is]. A segment approximately 50
microns in length was scanned at 1 to 3 second intervals. Mean
vessel diameter was determined by averaging all measurements
obtained during the plateau of the response.
Experimental protocols
Renal microvascular effects of insulin (actrapid; NOVO, Den-
mark) were assessed during different vasoconstrictor stimuli, that
is, NE (Sigma), Ang II (Sigma) and elevated renal perfusion
pressure (that is, myogenic stimuli). The vasoactive agents were
added directly to the perfusion medium, and the doses of the
agents were expressed as final concentrations in the perfusion
medium. The responses of the interlobular artery and the efferent
arteriole were observed at the distal portion and near the glomer-
ulus, respectively. Since afferent arteriolar constriction induced by
NE is rather uniform, but not by Ang II or elevated pressure, the
responses were evaluated at the midportion during NE-induced
constriction, near the glomerulus during Ang Il-induced constric-
tion, and near the interlobular artery during myogenic constric-
tion.
NE/Ang 11-induced vasoconstriction
The effects of insulin on NE- or Ang Il-induced constriction of
afferent arterioles, efferent arterioles, and interlobular arteries
were assessed. Initially, NE (0.3 jimol/liter) or Ang II (0.3
nmol/liter) was added to the perfusion medium to obtain basal
vascular tone. Following the determinations of baseline vasocon-
strictor responses, increasing doses of insulin were administered
(10, 30, 100, and 300 j.tU/ml), and their effects were evaluated. To
eliminate pressure-induced changes in vessel diameter, renal
perfusion pressure was maintained constant at 80 mm Hg
throughout the experimental protocol.
Pressure-induced vasoconstriction
Since myogenic vasoconstriction is observed only at the preglo-
merular vessels [16, 21], the ability of insulin to reverse myogenic
tone was evaluated at the interlobular artery and the afferent
arteriole. Initially, renal arterial pressure (RAP) was maintained
at 80 mm Hg. Then, RAP was raised from 80 to 180 mm Hg to
elicit myogenic tone of these vessels. Subsequently, 300 jiU/ml
insulin was added to the perfusion medium, and the vascular
response was assessed.
Additional experiments evaluated whether or not insulin pre-
vented myogenic constriction. Initially, RAP was raised from 80 to
180 mm Hg in a stepwise fashion by 20 mm Hg increments, and
the myogenic constriction of interlobular arteries and afferent
arterioles was observed at each RAP. After the addition of insulin
(300 jiU/ml), the ability of insulin to prevent myogenic constric-
tion of the same segments was re-assessed.
Role of nitric oxide in NE-induced vasoconstriction
To examine the role of nitric oxide in mediating insulin-induced
renal vascular response, the effect of nitro-L-arginine (N-Arg; 10
or 100 jimol/liter; Sigma) on insulin-induced dilation was assessed
during NE/Ang Il-induced constriction of renal microvessels.
Following the pretreatment with N-Arg, NE or Ang II was
administered to the perfusion medium. Then, the ability of insulin
to reverse NE- or Ang Il-induced constriction of renal microves-
sels was evaluated.
In additional series of experiments, the effects of insulin on
N-Arg-induced constriction of renal microvessels were evaluated.
Following the induction of renal vasoconstriction by N-Arg (100
jimol/liter; Sigma), insulin at a concentration of 300 jiU/ml was
added into the perfusion medium, and the responses of afferent
arterioles, efferent arterioles, and interlobular arteries were eval-
uated.
Analysis of data
All data are expressed as the mean SEM. Data were analyzed
by ANOVA followed by Newman-Keuls post-hoc test. P values <
0.05 were considered statistically significant.
Results
Effects of insulin on NE/Ang lI-induced vasoconstriction
Figure 1 depicts the representative tracings demonstrating the
dilation by insulin of NE-induced afferent arteriolar constriction.
As illustrated in Figure 1A, insulin caused dose-dependent dila-
tion of a NE-constricted afferent arteriole. When left untreated,
norepinephrine-induced vasoconstrictor response persisted for at
least 50 minutes (Fig. IB).
Figure 2 summarizes the effects of insulin on NE-induced
constriction of renal microvessels in kidneys from S-D rats. Insulin
(300 tiU/ml) had no effect on basal diameters of afferent arte-
rioles (19.2 0.6 and 19.5 0.4 jim, in the absence and presence
of insulin, respectively; N = 6,P> 0.5), efferent arterioles (17.0
0.6 and 16.9 0.8 jim, N = 6, P > 0.5), or interlobular arteries
(26.9 1.3 and 28.2 1.4 jim, N 6, P> 0.5). NE (0.3 jimol/liter)
caused prominent constriction of afferent arterioles (from 19.1
0.6 to 12.5 0.9 jim, N = 7, P < 0.01), efferent arterioles (from
17,0 0.6 to 12.0 0.6 jim, N = 6, P < 0.01), and interlobular
arteries (from 27.4 3.1 to 20.4 3.3 jim, N = 8,P < 0.05). The
subsequent addition of insulin resulted in marked dilation of these
vessels. Thus, 10 jiU/ml insulin increased the diameter of afferent
arterioles (15.8 0.9 jim, P < 0.01), efferent arterioles (14.4
0.7 jim, P < 0.01), and interlobular arteries (24.7 3.0 jim, P <
0.05). Further administration of insulin caused dose-dependent
dilation. At 300 jiU/ml, insulin completely reversed the NE-
induced constriction.
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Norepinephrine (0.3 LM)
Fig. 1. Representative tracings illustrating the effects of insulin on norepi-
nephrine-induced afferent arteriolar constriction. (A) Insulin inhibited nor-
epinephrine (0.3 LM)-induced constriction (that is, from 17.8 to 12.6 Lm)
in a dose-dependent manner (10 LU/ml, 14.8 I.tm; 30 U/ml, 16.1 m; 100
U/m1, 17.4 Irm; 300 PU/mI, 18.1 /Lm). (B) When left untreated, norepi-
nephrine-induced constriction was sustained throughout the experiment.
Similar to the effects on NE-induced constriction, insulin
elicited dose-dependent dilation of Ang IT-constricted renal mi-
crovessels (Fig. 3). Thus, Ang 11-induced constriction of afferent
arterioles (from 19.2 0.8 to 12.8 1.0 im, N = 6, P < 0.05),
efferent arterioles (from 17.8 0.8 to 12.8 0.5 .rm, N = 6, P <
0.05), and interlobular arteries (from 28.4 2.1 to 21.1 1.8 j.tm,
N = 7, P < 0.05) was reversed by 10 rU/m1 insulin by 40 8%,
49 7%, and 43 10%, respectively. At 300 pU/ml, insulin
completely dilated these vessels.
When left untreated, both norepinephrine- and angiotensin
Il-induced vasoconstriction was sustained throughout the experi-
mental protocols (Table 1).
Effects of insulin on myogenic vasoconstriction
Figure 4 depicts the representative tracings indicating the effect
of insulin on myogenic afferent arteriolar constriction in S-D rats.
As illustrated in the upper panel, insulin (300 U/mI) did not
reverse myogenic constriction of this vessel. In five afferent
arterioles and five interlobular arteries, insulin had no effect on
the myogenic vasoconstriction (afferent arteriole, 18.7 0.9,
14.4 0.8, and 14.5 0.9 m; interlobular artery, 27.8 2.7,
20.8 2.9, and 21.0 3.1 JLm, for control, pressure, and pressure
+ insulin, respectively). Similarly, insulin did not prevent the
myogenic afferent arteriolar constriction (lower panel).
The effects of insulin on myogenic constriction of afferent
arterioles and interlobular arteries are summarized in Figure 5.
Insulin did not inhibit the myogerlic constrictor responses of
afferent arterioles (Fig. 5A, N = 6). Thus, in the presence of 300
j.U/ml insulin, elevating RAP elicited pressure-dependent con-
striction, with 21 4% decrement in diameter observed at 180
mm Hg, a value not different from that observed in the absence of
insulin (22 3% decrement in diameter, P > 0.5). Similarly,
interlobular arteries (Fig. SB, N = 6) exhibited nearly the same
myogenic responsiveness in the absence and presence of insulin
(P> 0.2).
Role of nitric oxide in insulin-induced vasodilation
The addition of 100 mo1/liter N-Arg elicited marked constric-
tion of afferent arterioles (15 6%, N = 6, P < 0.01), efferent
arterioles (15 8%, N = 5, P < 0.01), and interlobular arteries
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Fig. 2. Effects of insulin on norepinephrine-constricted renal microvessels.
Insulin inhibited the constriction of afferent arterioles (N = 7), efferent
arterioles (N = 6), and interlobular arteries (N = 8) in a dose-dependent
manner. Results are mean SEM.
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Fig. 3. Effects of insulin of angiotensin 11-induced constriction of renal
micovessels. Insulin inhibited the constriction of afferent arterioles (N =
6), efferent arterioles (N = 6), and interlobular arteries (N = 7) in a
dose-dependent manner. Results are mean SEM.
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Table 1. Time course of norepinephrine- and angiotensin TI-induced vasoconstriction of renal microvessels
Vessels N Baseline 5 mm io mm 20 mm 30 mm 40 mm 50 mm
Norepinephrine AFF
EFF
ILA
6
5
5
19.4 0.8
17.5 0.7
26.9 2.9
12.3 0.8
12.1 0.6
21.3 35U
12.2 0.7a
12.1 0.7
21.5 37a
12.1 0.6a
12.3 0.8
21.6 39a
12.3 0.7
12.2 0.7
21.8 4.1
12.3 0.8a
12.1 0.8a
21.7 3.2a
12.4 0.6
12.2 0.7
21.8 3.8a
Angiotensin II AFF
EFF
ILA
5
6
5
19.1 0.7
17.0 0.8
27.3 3.8
12.4 0.7a
12.3 0.8a
21.7 3.7
12.1 0.9
12.3 0.5a
21.5 4.0
12.4 0.7a
12.4 0.7a
21.8 3.T
12.6 0.8'
12.5 0.6
21.9 3.8
12.6 0.7a
12.4 0.5a
22.1 3.9
12.7 0.8
12.6 0.8'
22.2 4.0k'
Results are expressed as means SEM (gm). Abbreviations are: AFF, afferent arteriole; EFF, efferent arteriole; ILA, interlobular artery.
P < 0.01 vs. baseline
:< 14
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Fig. 4. Failure of insulin to dilate myogenic afferent arteriolar vasoconstric-
don. Insulin did not reverse (upper) or prevent myogenic afferent arterio-
lar constriction (lower). Abbreviation RAP is renal arterial pressure.
(15 9%, N = 5, P < 0.01; Fig. 6). Tn contrast to the effects of
insulin on NEIAng IT-induced constriction, insulin (300 rU/ml) did
not reverse the N-Arg-induced constriction of these microvessels.
To determine whether nitric oxide mediates the insulin-induced
dilation of NE-constricted renal microvessels, the ability of insulin
to dilate renal microvessels was examined in the presence of
N-Arg (Fig. 7). N-Arg markedly blunted insulin-induced afferent
arteriolar dilation (Fig. 7A). In the presence of 10 moT/liter
N-Arg (N = 6), 300 jU/ml insulin dilated NE-constricted afferent
arterioles by 68 11% (baseline, 17.6 0.4; NE, 12.0 0.6;
insulin, 15.8 0.8 /.tm), in contrast to a prominent vasodilation in
the absence of N-Arg (104 6% reversal, N = 7, P < 0.01).
Furthermore, 100 mol/liter N-Arg markedly impaired the dila-
tion, with only 23 10% reversal by 300 jrU/ml insulin (N = 7).
Similarly, N-Arg dose-dependently impaired the insulin-induced
dilation of efferent arterioles (Fig. 7B; 10 tU/ml, N = 5; 100
j.rU/ml, N = 5) and interlobular arteries (Fig. 7C; 10 U/ml, N =
6; 100 .tU/ml, N = 6).
When these microvessels were constricted by Mg 11, N-Arg
also impaired the insulin-induced dilation of these vessels in a
dose-dependent manner (Fig. 8). Thus, 300 iU/ml insulin re-
turned the diameters of the afferent arteriole by only 51 9% and
24 5% in the presence of 10 mol/liter (N = 5) and 100
.rmol/liter N-Arg (N = 5), respectively, compared with 94 12%
reversal in the absence of N-Arg (N = 6). Similarly, N-Arg
diminished the insulin (300 j.rU/ml)-induced dilator action on the
efferent arteriole (control, 91 7% reversal, N = 6; 10 U/ml,
55 8% reversal, N = 6; 100 .rU/ml, 20 9% reversal, N = 6)
and the interlobular artery (control, 91 7% reversal, N = 7; 10j.tU/ml, 50 8% reversal, N = 5; 100 j.tU/ml, 24 9% reversal,
N=6).
Discussion
It has been demonstrated that insulin resistance and/or hyper-
insulinemia are associated with systemic hypertension [1—3]. Con-
versely, correction of insulin resistance by weight reduction lowers
systemic blood pressure in obese subjects [22, 23]. Thus, insulin is
not only a glucoregulatory hormone, but also plays an important
role in the regulation of the systemic vascular tone [5, 6].
Furthermore, several lines of investigation have demonstrated
that insulin dilates renal resistance vessels [7—9]. Despite the
recognition of the vasoactive property of insulin, the action of
insulin on renal microcirculation has not been characterized fully.
Furthermore, the mechanisms of insulin-induced vascular actions
remain undetermined.
The present study has demonstrated that insulin exerts diverse
vasomotor action on the renal microvasculature. Thus, insulin
Insulin 300,u U/mi
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Fig. 5. Mean data summarizing the failure of insulin to inhibit myogenic
constriction of the afferent arteriole and the interlobular artery. Insulin (300
p.U1m1) had no effect on myogenic constriction of the afferent arteriole (A)
or the interlobular artery (B). Results are mean SEM. Symbols are: (0)
control; (A) insulin-treated.
A
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Fig. 7. Effects of nitro-L-arginine (N-Arg) on
insulin-induced dilation of renal microvessels
during norepinephrine-induced vasoconstriction.
Inhibition of nitric oxide synthesis by N-Arg (10
/.LM, A; 100 .LM, •) markedly prevented the
insulin-induced dilation of afferent arterioles
(A), efferent arterioles (B), and interlobular
arteries (C). Results are mean SEM.
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dilates both pre- and postglomerular renal microvessels in a
dose-dependent manner, when the vessels are constricted by NE
or Ang II. In striking contrast, insulin, even at pharmacologic
doses (such as 300 jiUIml), fails to inhibit the myogenic constric-
tion of the preglomerular vessels. Additionally, renal vasoconstric-
tion induced by blocking nitric oxide is refractory to insulin. Thus,
the present study reveals disparate action of insulin on the renal
vasculature; the ability of insulin to affect renal microvascular tone
varies, depending greatly on the nature of the underlying vascular
tone.
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Fig. 8. Effects of nitro-L-arginine (N-Arg) on
insulin-induced dilation of renal microvessels
during angiotensin Il-induced vasoconstriction.
Inhibition of nitric oxide synthesis by N-Arg (10
tLM, A; 100 rM; •) markedly prevented the
insulin-induced dilation of afferent arterioles
(A), efferent arterioles (B), and interlobular
arteries (C). Results are mean SCM.
The renal hemodynamic effects of insulin remain incompletely
determined. Previous studies demonstrated that insulin dilates [5,
6] or has no effect on the forearm or leg vessels [24, 25]. Thus,
controversy attends the effects of insulin on the systemic vascular
tone. In the renal microvasculature, Juncos and Ito [9] have
demonstrated that insulin inhibits NE-induced vasoconstriction in
isolated perfused renal microvessels, although the dilation is seen
only at the ciferent arteriole. In addition, Cohen, McCarthy and
Stoff [8] demonstrated that insulin caused increases in RPF and
GFR without changes in filtration fraction, and suggested that
insulin dilated both affcrcnt and efferent arterioles. Furthermore,
Tucker et al [7] demonstrated that using the micropuncture study,
insulin decreased afferent arteriolar resistance, and tended to
reduce efferent arteriolar resistance. The present findings that
insulin exerts direct dilator action on the renal mierovaseulature
in in vitro hydroncphrotic kidneys are thus consistent with the in
vivo observations from other laboratories described above [7, 8],
and could provide direct evidence for the renal microvascular
action of insulin.
Although vascular action of insulin has been extensively inves-
tigated, the mechanisms of insulin-induced vasodilation have not
been fully determined. Insulin is reported to stimulate Na,K-
ATPase [26], Ca-ATPase [27], and agonist-induced calcium influx
[13, 14] in vascular smooth muscle. Recently, a couple of studies
provide strong evidence that nitric oxide contributes to the
insulin-induced changes in vascular tone. Steinberg et al [11] have
demonstrated that the inhibition of nitric oxide synthesis nearly
completely abrogates the insulin-induced vasodilation in skeletal
muscle, suggesting a dominant role of nitric oxide in mediating the
vascular action of insulin. Furthermore, Scherrer et al [12]
demonstrated that blockade of nitric oxide prevented insulin-
induced dilation of forearm vessels. The present study reveals that
insulin does not reverse N-Arg-induced renal vasoconstriction
(Fig. 6). Moreover, N-Arg markedly inhibits the insulin-induced
dilation of NE- (Fig. 7) and Ang 11-constricted renal microvessels
(Fig. 8). These observations strongly suggest that nitric oxide
mediates the insulin-induced dilation. In contrast, Juneos and Ito
[9] failed to demonstrate the role of nitric oxide in mediating the
insulin-induced dilation of isolated rabbit renal mierovessels. The
discrepancy between these observations is unclear, but it is
possible that insulin activates multiple vasodilator mechanisms,
and different mechanisms dominate depending on experimental
settings. For example, Cohen et a! [8] reported that in the isolated
perfused rat kidney, insulin caused renal vasodilation by a pros-
taglandin-dependeni process. Further investigations are required
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to elucidate the role of nitric oxide in mediating insulin-induced
renal vasodilation.
The present study demonstrates that, despite marked vasodila-
tor action during NE- and Ang lI-induced constriction, insulin did
not dilate the renal microvasculature when the vessel was con-
stricted by increased pressure (that is, myogenic vasoconstriction).
The disparate action of insulin closely resembles that of cyclic
GMP-related vasodilators. Therefore, we previously demon-
strated that atrial natriuretic peptide, nitroprusside, and 8-bromo
cyclic GMP had no effects on myogenic afferent arteriolar con-
striction in the isolated perfused hydronephrotic kidney, whereas
these substances markedly inhibited the NE-induced constriction
[17]. Furthermore, acetyicholine produced both transient and
sustained components of afferent arteriolar dilation during NE-
induced constriction, and the sustained component was inhibited
by blockade of nitric oxide [18]. In contrast, acetylcholine had no
sustained dilator effect when the vessel was constricted by pres-
sure. Thus, insulin, cyclic GMP-related vasodilators and acetyl-
choline exhibit a similar action ott the renal microvasculature
during NE-induced and myogenic vasoconstriction. Finally, the
inhibition of nitric oxide by N-Arg does not affect the myogenic
contractility of the superficial afferent arteriole [28, 291. Collec-
tively, the differing action of insulin on NE-induced and myogenic
vasoconstriction is consistent with the formulation that cyclic
GMP-related vasodilators inhibit receptor-mediated, but not
myogenic constriction, and may thus support the contention that
insulin-induced dilation is mediated by nitric oxide.
In conclusion, the present study demonstrates that insulin
dilates the NE/Mg Il-induced constriction of the afferent arte-
riole, the efferent arteriole, and the interlobular artery. Further-
more, the N-Arg inhibits the insulin-induced vasodilation, sug-
gesting a role of nitric oxide in mediating the renal vasodilation. In
contrast, when the vessels are constricted by elevated pressure,
insulin fails to inhibit this type of constriction. Thus, insulin is
capable of dilating the renal microvasculature, but the dilator
action of insulin varies, depending on the underlying vasoconstric-
tor tone.
Reprint requests to Takao Saruta, M.D., Department of Internal Medicine,
School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo
160, Japan.
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